Study mechanistic interactions between estrogen signaling and incretin pathways in humans, translational work that can guide dosing and adjunctive therapies
Clinical trials show an average weight loss of 15-20% of body weight over 72 weeks, with many patients seeing noticeable results within the first few months
And indirect costs from productivity losses are borne by the employer
GLP-1 therapy is most effective as part of long-term clinical management, not a short course
To view a copy of this licence, visit About this article Cite this article Tartaglia, E., Bucci, T., Rossi, M
According to the prescribing information approved by the Medicines and Healthcare products Regulatory Agency (MHRA), the day of weekly administration can be changed if necessary, as long as the time between two doses is at least 72 hours (three days)